nach oben

Erschienen in:

01.07.2015 | Original Article

Nitric oxide-mediated cytotoxic effect induced by zoledronic acid treatment on human gingival fibroblasts

verfasst von: Marianna De Colli, Susi Zara, Viviana di Giacomo, Antonia Patruno, Guya Diletta Marconi, Marialucia Gallorini, Vincenzo Luca Zizzari, Giulia Tetè, Amelia Cataldi

Erschienen in: Clinical Oral Investigations | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

Objectives

The aim of our work was to evaluate the role of nitric oxide (NO) in the in vitro response of human gingival fibroblasts (HGFs) to 1, 5, 10, and 100 μM doses of zoledronic acid (ZA), a bisphosphonate largely used in the clinical practice and for which several adverse effects are reported.

Materials and methods

Phase contrast microscopy and live/dead staining were used to evaluate HGFs morphology; cell viability, collagen type I and interleukin 6 (IL-6) secretion were evaluated by 3-[4,5-dimethyl-thiazol-2-yl-]-2,5-diphenyl tetrazolium bromide (MTT) and enzyme-linked immunosorbent assay (ELISA) assays. Reactive oxygen species (ROS) production and mitochondrial membrane potential were evaluated by flow cytometry; NO production and NOS activity by spectrophotometric analysis; endothelial NOS (eNOS) and neuronal NOS (nNOS) expression by immunofluorescence.

Results

Viable fibroblasts are evidenced in control sample while floating dead cells and cells close to detachment phase in ZA-treated sample, in agreement with decreased level of collagen type I. Control sample shows higher number of viable cells respect to ZA-treated one and ROS production increases when ZA is added. Released NO in ZA-treated sample appears higher and NO overproduction is related to increased nNOS activity. IL-6 secretion level is higher in ZA-treated sample than in control one.

Conclusions

Our results suggest ROS involvement in NO overproduction, due to nNOS recruitment, both at low and high doses. In turn, NO release seems to be able to trigger the inflammatory response only when high doses are administered, thus confirming the ZA cytotoxic effect on HGFs.

Clinical relevance

The knowledge of ZA-mediated cytotoxicity mechanisms on HGFs allows to better understand drug pharmacological activity.

Markiewicz MR, Margarone JE 3rd, Campbell JH, Aguirre A (2005) Bisphosphonate-associated osteonecrosis of the jaws: a review of current knowledge. J Am Dent Assoc 136:1669–74PubMedCrossRef

Hillner BE, Ingle JN, Chlebowski RT et al. (2004) American Society of Clinical Oncology. American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol 2003; 21:4042–57. Erratum in: J Clin Oncol 2004; 22: 1351

Rosen LS, Gordon D, Kaminski M et al (2001) Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial. Cancer J 7:377–87PubMed

Vincenzi B, Santini D, Dicuonzo G et al (2005) Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients. J Interferon Cytokine Res 25:144–51PubMedCrossRef

Major P (2002) The use of zoledronic acid, a novel, highly potent bisphosphonate, for the treatment of hypercalcemia of malignancy. Oncologist 7:481–91PubMedCrossRef

Russell RG (2007) Bisphosphonates: mode of action and pharmacology. Pediatrics 119(2):S150–62PubMedCrossRef

Goffinet M, Thoulouzan M, Pradines A et al (2006) Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells. BMC Cancer 15(6):60CrossRef

Civitelli R, Napoli N, Armamento-Villareal R (2007) Use of intravenous bisphosphonates in osteoporosis. Curr Osteoporos Rep 5:8–13PubMedCrossRef

Rizos EC, Milionis HJ, Elisaf MS (2006) Fever with rash following zoledronic acid administration. Clin Exp Rheumatol 24:455PubMed

10.

Bagan JV, Jimenez Y, Murillo J et al (2006) Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions. Study of 20 cases. Oral Oncol 42:327–9PubMedCrossRef

11.

Kyrgidis A, Triardis S, Antoniades K (2009) Effects of bisphosphonates on keratinocytes and fibroblasts having a role in the development of osteonecrosis of the jaw. Byosciences Hypotheses 2:153–159CrossRef

12.

Reid IR, Bolland MJ, Grey AB (2007) Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? Bone 41:318–20PubMedCrossRef

13.

Hoefert S, Schmitz I, Weichert F, Gaspar M, Eufinger H (2014) Macrophages and bisphosphonate-related osteonecrosis of the jaw (BRONJ): evidence of local immunosuppression of macrophages in contrast to other infectious jaw diseases. Clin Oral Investig

14.

Scheper M, Chaisuparat R, Cullen K, Meiller T (2010) A novel soft-tissue in vitro model for bisphosphonate-associated osteonecrosis. Fibrogenesis Tissue Repair 3:6PubMedCentralPubMedCrossRef

15.

Cozin M, Pinker BM, Solemani K et al (2011) Novel therapy to reverse the cellular effects of bisphosphonates on primary human oral fibroblasts. J Oral Maxillofac Surg 69:2564–78PubMedCentralPubMedCrossRef

16.

Açil Y, Möller B, Niehoff P et al (2012) The cytotoxic effects of three different bisphosphonates in-vitro on human gingival fibroblasts, osteoblasts and osteogenic sarcoma cells. J Craniomaxillofac Surg 40:e229–35PubMedCrossRef

17.

Ohnuki H, Izumi K, Terada M et al (2012) Zoledronic acid induces S-phase arrest via a DNA damage response in normal human oral keratinocytes. Arch Oral Biol 57:906–17PubMedCrossRef

18.

Kang SW, Park HJ, Ban JY, Chung JH, Chun GS, Cho JO (2011) Effects of nicotine on apoptosis in human gingival fibroblasts. Arch Oral Biol 56:1091–7PubMedCrossRef

19.

Cataldi A, Zara S, Rapino M, Patruno A, di Giacomo V (2013) Human gingival fibroblasts stress response to HEMA: a role for protein kinase C α. J Biomed Mater Res A 101:378–84PubMedCrossRef

20.

Alfadda AA, Sallam RM (2012) Reactive oxygen species in health and disease. J Biomed Biotechnol 2012:936486PubMedCentralPubMedCrossRef

21.

Park HS, Lee SH, Park D et al (2004) Sequential activation of phosphatidylinositol 3-kinase, beta Pix, Rac1, and Nox1 in growth factor-induced production of H₂O₂. Mol Cell Biol 24:4384–94PubMedCentralPubMedCrossRef

22.

Beckman KB, Ames BN (1998) The free radical theory of aging matures. Physiol Rev 78:547–81PubMed

23.

Tousoulis D, Kampoli AM, Tentolouris C, Papageorgiou N, Stefanadis C (2012) The role of nitric oxide on endothelial function. Curr Vasc Pharmacol 10:4–18PubMedCrossRef

24.

Chung HT, Pae HO, Choi BM, Billiar TR, Kim YM (2001) Nitric oxide as a bioregulator of apoptosis. Biochem Biophys Res Commun 282:1075–9PubMedCrossRef

25.

Nathan C (2002) Points of control in inflammation. Nature 420:846–52PubMedCrossRef

26.

Titheradge MA (1998) The enzymatic measurement of nitrate and nitrite. Methods Mol Biol 100:83–91PubMed

27.

Patruno A, Pesce M, Marrone A et al (2012) Activity of matrix metallo proteinases (MMPs) and the tissue inhibitor of MMP (TIMP)-1 in electromagnetic field-exposed THP-1 cells. J Cell Physiol 227:2767–74PubMedCrossRef

28.

Defrere S, Lousse JC, Gonzalez-Ramos R et al (2008) Potential involvement of iron in the pathogenesis of peritoneal endometriosis. Mol Hum Reprod 14:377–385PubMedCrossRef

29.

Zhen J, Lu H, Wang XQ, Vaziri ND, Zhou XJ (2008) Upregulation of endothelial and inducible nitric oxide synthase expression by reactive oxygen species. Am J Hypertens 21:28–34PubMedCrossRef

30.

Murata M, Thanan R, Ma N, Kawanishi S (2012) Role of nitrative and oxidative DNA damage in inflammation-related carcinogenesis. J Biomed Biotechnol 2012:623019PubMedCentralPubMedCrossRef

31.

Jiang ZL, Zhu X, Diamond MP, Abu-Soud HM, Saed GM (2008) Nitric oxide synthase isoforms expression in fibroblasts isolated from human normal peritoneum and adhesion tissues. Fertil Steril 90:769–74PubMedCentralPubMedCrossRef

32.

Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 87:1620–1624PubMedCentralPubMedCrossRef

33.

Maron BA, Michel T (2012) Subcellular localization of oxidants and redox modulation of endothelial nitric oxide synthase. Circ J 76:2497–512PubMedCrossRef

34.

Medina EA, Morris IR, Berton MT (2010) Phosphatidylinositol 3-kinase activation attenuates the TLR2-mediated macrophage proinflammatory cytokine response to Francisella tularensis live vaccine strain. J Immunol 185:7562–72PubMedCrossRef

35.

Tipton DA, Seshul BA, Dabbous MKH (2011) Effect of bisphosphonates on human gingival fibroblast production of mediators of osteoclastogenesis: RANKL, osteoprotegerin and interleukin-6. J Periodontal Res 46:39–47PubMedCrossRef

36.

Saracino S, Canuto RA, Maggiora M et al (2012) Exposing human epithelial cells to zoledronic acid can mediate osteonecrosis of jaw: an in vitro model. J Oral Pathol Med 41:788–92PubMedCrossRef

37.

Fraisl P (2013) Crosstalk between oxygen- and nitric oxide-dependent signaling pathways in angiogenesis. Exp Cell Res 319:1331–9PubMedCrossRef

38.

Cooke JP (2003) NO and angiogenesis. Atheroscler Suppl 4:53–60PubMedCrossRef

39.

Pabst AM, Ziebart T, Ackermann M, Konerding MA, Walter C (2014) Bisphosphonates’ antiangiogenic potency in the development of bisphosphonate-associated osteonecrosis of the jaws: influence on microvessel sprouting in an in vivo 3D Matrigel assay. Clin Oral Investig 18:1015–22PubMedCrossRef

40.

Ziebart T, Pabst A, Klein MO, Kämmerer P, Gauss L, Brüllmann D, Al-Nawas B, Walter C (2011) Bisphosphonates: restrictions for vasculogenesis and angiogenesis:inhibition of cell function of endothelial progenitor cells and mature endothelial cells in vitro. Clin Oral Investig 15:105–11PubMedCrossRef

Titel: Nitric oxide-mediated cytotoxic effect induced by zoledronic acid treatment on human gingival fibroblasts
verfasst von: Marianna De Colli
Susi Zara
Viviana di Giacomo
Antonia Patruno
Guya Diletta Marconi
Marialucia Gallorini
Vincenzo Luca Zizzari
Giulia Tetè
Amelia Cataldi
Publikationsdatum: 01.07.2015
Verlag: Springer Berlin Heidelberg
Erschienen in: Clinical Oral Investigations / Ausgabe 6/2015
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI: https://doi.org/10.1007/s00784-014-1344-9

Neu im Fachgebiet Zahnmedizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

19.04.2024 Vorhofflimmern Nachrichten

Werden Personen mit Vorhofflimmern in der Blanking-Periode nach einer Katheterablation gegen eine bestehende Parodontitis behandelt, verbessert dies die Erfolgsaussichten. Dafür sprechen die Resultate einer prospektiven Untersuchung.

Invasive Zahnbehandlung: Wann eine Antibiotikaprophylaxe vor infektiöser Endokarditis schützt

11.04.2024 Endokarditis Nachrichten

Bei welchen Personen eine Antibiotikaprophylaxe zur Prävention einer infektiösen Endokarditis nach invasiven zahnärztlichen Eingriffen sinnvoll ist, wird diskutiert. Neue Daten stehen im Einklang mit den europäischen Leitlinienempfehlungen.

Zell-Organisatoren unter Druck: Mechanismen des embryonalen Zahnwachstums aufgedeckt

08.04.2024 Zahnmedizin Nachrichten

Der Aufbau von Geweben und Organen während der Embryonalentwicklung wird von den Zellen bemerkenswert choreografiert. Für diesen Prozess braucht es spezielle sogenannte „Organisatoren“. In einer aktuellen Veröffentlichung im Fachjournal Nature Cell Biology berichten Forschende durch welchen Vorgang diese Organisatoren im Gewebe entstehen und wie sie dann die Bildung von Zähnen orchestrieren.

Die Oralprophylaxe & Kinderzahnheilkunde umbenannt

11.03.2024 Kinderzahnmedizin Nachrichten

Infolge der Umbenennung der Deutschen Gesellschaft für Kinderzahnheilkunde in Deutsche Gesellschaft für Kinderzahnmedizin (DGKiZ) wird deren Mitgliederzeitschrift Oralprophylaxe & Kinderzahnheilkunde in Oralprophylaxe & Kinderzahnmedizin umbenannt. Aus diesem Grunde trägt die erste Ausgabe in 2024 erstmalig den neuen Titel.

Bestellen Sie unseren kostenlosen Newsletter Update Zahnmedizin und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Abstract

Objectives

Materials and methods

Results

Conclusions

Clinical relevance

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2015

Narrow- versus mini-implants at crestal and subcrestal bone levels. Experimental study in beagle dogs at three months

Fluoride varnishes containing calcium glycerophosphate: fluoride uptake and the effect on in vitro enamel erosion

A new three-component formulation for the efficient whitening of teeth (Carbamide Plus)

Survival analysis of dental implants and implant-retained prostheses in oral cancer patients up to 20 years

Periosteal microcirculatory reactions in a zoledronate-induced osteonecrosis model of the jaw in rats

A case-control study on oral health-related quality of life in kidney disease patients undergoing haemodialysis

Neu im Fachgebiet Zahnmedizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Invasive Zahnbehandlung: Wann eine Antibiotikaprophylaxe vor infektiöser Endokarditis schützt

Zell-Organisatoren unter Druck: Mechanismen des embryonalen Zahnwachstums aufgedeckt

Die Oralprophylaxe & Kinderzahnheilkunde umbenannt

Newsletter